Guided Therapeutics Announces Start of Chinese Clinical Trial for Approval to Market and Sell LuViva in China

Guided Therapeutics Ships LuViva Devices to China for Start of Clinical Trial; Receives Additional $100,000 Payment

Guided Therapeutics Receives Notification of Successful Clinical Trial Regulatory Review and $133,000 Payment from China

New European Published Study Shows LuViva Detects 20% More Precancerous and Cancerous Cervical Disease than HPV Test

Guided Therapeutics Receives News from Chinese State Food and Drug Administration that LuViva Meets Product Technical Requirements

Guided Therapeutics Replaces Convertible Note Facility and Significantly Reduces Dilution

Guided Therapeutics Closes $2.114 Million Series F Preferred Stock Financing

Guided Therapeutics Raises US $1.1 Million in New Preferred Stock Offering

Guided Therapeutics Makes Final Payment to GPB Capital Holdings for Secured Notes

Guided Therapeutics Receives New Half Million Dollar Purchase Order from China